SwinnJAK (Tofacitinib 5mg)
Strength:Tofacitinib 5 mg tablets
SwinnJAK contains Tofacitinib, an oral JAK1 and JAK3 inhibitor that blocks the JAK-STAT cytokine signalling pathway to suppress immune-driven inflammation. Approved for rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, it is also widely studied in dermatology for alopecia areata, vitiligo, and atopic dermatitis.
For more information contact your treating Physician.
₹754.00




